The so-called new coronary nucleic acid rapid test, is to meet the needs of fever clinic, emergency and other application scenarios, in the clinical development of new coronary virus nucleic acid detection methods towards immediate detection (POCT), but because these methods fail to achieve the ideal POCT requirements, the industry is commonly referred to as "rapid test" or "The new coronavirus nucleic acid rapid test.
In August 2021, the Chinese Journal of Medical Laboratory published the "Expert Consensus on Clinical Standardization of Novel Coronavirus Nucleic Acid Rapid Test". In the Consensus, the definition of "new coronavirus rapid nucleic acid test" is clearly defined: compared with the conventional 2019-nCoV new coronavirus rapid nucleic acid test, the time required for the whole process of sample detection is significantly shortened, and the instrument is miniaturized (some new coronavirus rapid nucleic acid test systems are portable), with or without nucleic acid extraction, amplification Detection of integrated features.
What is the difference between the New Crown Nucleic Acid Rapid Test and the conventional New Crown Nucleic Acid Test?
New crown nucleic acid rapid test product form convenient (generally only need to support a device to complete the nucleic acid test), the operation process is simpler, the detection time is also greatly shortened.
Where is the main application of New Crown Nucleic Acid Rapid Test currently?
At present, Newguan Nucleic Acid Rapid Test is mainly used in fever clinics, airport customs and other scenarios that require rapid issuance of nucleic acid test reports.
Recently, the global epidemic continues to evolve and virus variants are appearing one after another, putting higher demands on the prevention and control work. The New Crown Nucleic Acid Rapid Test is the trend in the normalization of epidemic situations.
It enables a more rapid response for epidemic prevention and control, greatly reduces the time for virus outbreak during the detection of positive cases, and is an indispensable force for epidemic prevention and control.
However, due to the limitations of technological development, many clinical methods and equipment for rapid nucleic acid testing are not sensitive enough, and are prone to sample leakage and detection contamination, resulting in greatly reduced results of rapid nucleic acid testing for new coronas. At present, the state has issued a relevant notice to the market management of the new crown nucleic acid rapid test reagents and instruments.
In the "Notice on National Capacity Building of New Coronavirus Nucleic Acid Testing" (Joint Prevention and Control Mechanism Medical Hair (2021) No. 33), it is required to: equip with approved rapid testing equipment of suitable throughput of new coronavirus nucleic acid, and select rapid testing reagents of new coronavirus nucleic acid with stable performance and high sensitivity to ensure the sensitivity of rapid testing of new coronavirus nucleic acid.
In the "Notice on Further Strengthening the New Coronavirus Nucleic Acid Testing in Fever Clinics", the annex details the manufacturers of the New Coronavirus rapid test equipment that have been certified.
